Average Co-Inventor Count = 7.09
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoffmann-la Roche Inc. (68 from 4,942 patents)
2. Unversität Zürich (1 from 164 patents)
3. Eidgenoessische Technische Hochschule Zuerich (1 from 3 patents)
4. Eidgenössische Technische Hochschule Zürcih (1 from 1 patent)
5. F. Hoffmann-la Roche Ag (168 patents)
6. Eidgenossische Technische Hochschule Zurich (59 patents)
68 patents:
1. 12281124 - Heterocyclic compounds as monoacylglycerol lipase inhibitors
2. 11814375 - Heterocyclic compounds
3. 11802133 - Heterocyclic compounds as monoacylglycerol lipase inhibitors
4. 11655243 - Pyridine and pyrazine derivatives as preferential cannabinoid 2 agonists
5. 11608347 - Octahydropyrido[1,2-alpha]pyrazines as MAGL inhibitors
6. 11420961 - Heterocyclic compounds
7. 11390610 - Piperazine derivatives as MAGL inhibitors
8. 11339120 - Phenyl derivatives as cannabinoid receptor 2 agonists
9. 11117903 - Pyridine derivatives
10. 10457686 - [1,2,3]triazolo[4,5-D]pyrimidine derivatives
11. 10457685 - [1,2,3]triazolo[4,5-D]pyrimidine derivatives with affinity for the type-2 cannabinoid receptor
12. 10457684 - [1,2,3]triazolo[4,5-d]pyrimidine derivatives
13. 10450321 - [1,2,3]triazolo[4,5-D]pyrimidine derivatives
14. 10308659 - Pyridine derivatives
15. 10227308 - Radiolabeled cannabinoid receptor 2 ligand